1-6 of 6
Emanuele Guardalben
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of COVID-19 Pandemic Waves on Outcomes of Patients with Previously Untreated Advanced Follicular Lymphoma Enrolled in the Urban Ambispective Study in Italy

Antonio Pinto, Emanuele Guardalben, Marica Battista, Giulia Chiara Gazzoli, Michele Merli, Annalisa Chiarenza, Tommasina Perrone, Attilio Guarini, Nicola Di Renzo, Carlo Visco, Agostino Tafuri, Roberta Murru, Felicetto Ferrara, Jacopo Olivieri, Attilio Olivieri, Andrés J M Ferreri, Marco Ladetto, Pier Luigi Zinzani, Luca Arcaini, Giuseppe Gritti
Journal: Blood
Blood (2022) 140 (Supplement 1): 6504–6506.
https://doi.org/10.1182/blood-2022-166486
Published: 2022
Journal Articles

Obinutuzumab-Based Immunochemotherapy Mitigates Early Progression Risk with a Substantial 2-Year Progression-Free Survival (PFS) in Patients with Previously Untreated Advanced Follicular Lymphoma and a FLIPI Score ≥2: An Interim Analysis of the Ambispective Urban Study

Antonio Pinto, Emanuele Guardalben, Marco Caltagirone, Chiara Piparo, Caterina Patti, Elsa Pennese, Sonya De Lorenzo, Vincenzo Pavone, Ugo Consoli, Francesco Piazza, Monia Capponi, Benedetta Puccini, Luca Baldini, Alessandro Pulsoni, Stefan Hohaus, Piero Maria Stefani, Simone Santini, Vittorio Ruggero Zilioli, Caterina Stelitano, Luca Arcaini, Giuseppe Gritti, Marco Ladetto, Pier Luigi Zinzani
Journal: Blood
Blood (2022) 140 (Supplement 1): 3638–3641.
https://doi.org/10.1182/blood-2022-165977
Published: 2022
Journal Articles

In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI

Clinical Trials & Observations
Gian Matteo Rigolin, Maurizio Cavallari, Francesca Maria Quaglia, Luca Formigaro, Enrico Lista, Antonio Urso, Emanuele Guardalben, Carmine Liberatore, Danilo Faraci, Elena Saccenti, Cristian Bassi, Laura Lupini, Maria Antonella Bardi, Eleonora Volta, Elisa Tammiso, Aurora Melandri, Massimo Negrini, Francesco Cavazzini, Antonio Cuneo
Journal: Blood
Blood (2017) 129 (26): 3495–3498.
https://doi.org/10.1182/blood-2017-03-772285
Published: 2017
Includes: Supplemental data
Journal Articles

EUTOS Score Identifies Cases with Poor Outcome in Patients with Early Chronic Phase Chronic Myeloid Leukemia, Though Not Predictive for Optimal Response to Imatinib

Mario Tiribelli, Massimiliano Bonifacio, Elisabetta Calistri, Gianni Binotto, Elena Maino, Luciana Marin, Emanuele Guardalben, Antonio Branca, Filippo Gherlinzoni, MD, Gianpietro Semenzato, Renato Bassan, MD, Giovanni Pizzolo, MD, Renato Fanin
Journal: Blood
Blood (2012) 120 (21): 3778.
https://doi.org/10.1182/blood.V120.21.3778.3778
Published: 2012
Journal Articles

The Sesquiterpene Oil α-Bisabolol Induces Apoptosis of B-Chronic Lymphocytic Leukemia Primary Cells

Massimiliano Bonifacio, Antonella Rigo, Angela Bonalumi, Emanuele Guardalben, Ilaria Nichele, Cinzia Sissa, Elisabetta Cavalieri, Christian Bergamini, Giovanni Pizzolo, Hisanori Suzuki, Fabrizio Vinante
Journal: Blood
Blood (2011) 118 (21): 1319.
https://doi.org/10.1182/blood.V118.21.1319.1319
Published: 2011
Journal Articles

Mitochondrial-Mediated Apoptosis by the Sesquiterpene Oil α-Bisabolol and Its Synergism with Imatinib and Nilotinib In BCR-ABL + Cells

Massimiliano Bonifacio, Antonella Rigo, Elisabetta Cavalieri, Emanuele Guardalben, Christian Bergamini, Giovanni Pizzolo, Hisanori Suzuki, Fabrizio Vinante
Journal: Blood
Blood (2010) 116 (21): 4456.
https://doi.org/10.1182/blood.V116.21.4456.4456
Published: 2010